|
1
|
Posner J, Polanczyk GV and Sonuga-Barke E:
Attention-deficit hyperactivity disorder. Lancet. 395:450–462.
2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Harpin VA: The effect of ADHD on the life
of an individual, their family, and community from preschool to
adult life. Arch Dis Child. 90 (Suppl 1):2–7. 2005.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Peasgood T, Bhardwaj A, Biggs K, Brazier
JE, Coghill D, Cooper CL, Daley D, De Silva C, Harpin V, Hodgkins
P, et al: The impact of ADHD on the health and well-being of ADHD
children and their siblings. Eur Child Adolesc Psychiatry.
25:1217–1231. 2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Barkley RA: The high economic costs
associated with ADHD. ADHD Rep. 28:10–12. 2020.
|
|
5
|
Mehta TR, Monegro A, Nene Y, Fayyaz M and
Bollu PC: Neurobiology of ADHD: A review. Curr Dev Disord Rep.
6:235–240. 2019.
|
|
6
|
Levy F and de Leon J: Dopamine ADHD/OCD
theories: Is glutamine part of the story? Neurotransmitter (Houst).
2(e891)2015.
|
|
7
|
Wu G: Functional amino acids in growth,
reproduction, and health. Adv Nutr. 1:31–37. 2010.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Valenzuela CF, Puglia MP and Zucca S:
Focus on: Neurotransmitter systems. Alcohol Res Health. 34:106–120.
2011.PubMed/NCBI
|
|
9
|
Saudubray JM and Garcia-Cazorla A: An
overview of inborn errors of metabolism affecting the brain: From
neurodevelopment to neurodegenerative disorders. Dialogues Clin
Neurosci. 20:301–325. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Bornstein RA, Baker GB, Carroll A, King G,
Wong JT and Douglass AB: Plasma amino acids in attention deficit
disorder. Psychiatry Res. 33:301–306. 1990.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Zavala M, Castejón HV, Ortega PA, Castejón
OJ, Marcano de Hidalgo A and Montiel N: Imbalance of plasma amino
acids in patients with autism and subjects with attention
deficit/hyperactivity disorder. Rev Neurol. 33:401–408.
2001.PubMed/NCBI
|
|
12
|
Stern M, Perez L, Johnstone J, Gracious B,
Leung B, Tost G, Arnold E, Hatsu I and Kopec R: Using Metabolomics
to classify the underlying effects of multi-nutrient
supplementation in ADHD youth. Curr Dev Nutr. 4 (Suppl
2)(1351)2020.
|
|
13
|
Bergwerff CE, Luman M, Blom HJ and
Oosterlaan J: No tryptophan, tyrosine and phenylalanine
abnormalities in children with attention-deficit/hyperactivity
disorder. PLoS One. 11(e0151100)2016.PubMed/NCBI View Article : Google Scholar
|
|
14
|
General Assembly of the World Medical
Association. World Medical Association Declaration of Helsinki:
Ethical principles for medical research involving human subjects. J
Am Coll Dent. 81:14–18. 2014.PubMed/NCBI
|
|
15
|
International Statistical Classification
of Diseases and Related Health Problems 10th Revision (ICD-10):
Chapter V Mental and behavioural disorders (F00-F99). Behavioural
and emotional disorders with onset usually occurring in childhood
and adolescence (F90-F98). https://icd.who.int/browse10/2019/en#/F90-F98.
Accessed December 8, 2020.
|
|
16
|
DuPaul GJ, Power TJ, Anastopoulos AD and
Reid R: ADHD Rating Scale-IV: Checklists, norms, and clinical
interpretation. Guilford Press, 1998.
|
|
17
|
Goff DC, Hennen J, Lyoo IK, Tsai G, Wald
LL, Evins AE, Yurgelun-Todd DA and Renshaw PF: Modulation of brain
and serum glutamatergic concentrations following a switch from
conventional neuroleptics to olanzapine. Biol Psychiatry.
51:493–497. 2002.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Maltezos S, Horder J, Coghlan S, Skirrow
C, O'Gorman R, Lavender TJ, Mendez MA, Mehta M, Daly E, Xenitidis
K, et al: Glutamate/glutamine and neuronal integrity in adults with
ADHD: A proton MRS study. Transl Psychiatry. 4(e373)2014.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Carrey NJ, MacMaster FP, Gaudet L and
Schmidt MH: Striatal creatine and glutamate/glutamine in
attention-deficit/hyperactivity disorder. J Child Adolesc
Psychopharmacol. 17:11–17. 2007.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Bauer J, Werner A, Kohl W, Kugel H,
Shushakova A, Pedersen A and Ohrmann P: Hyperactivity and
impulsivity in adult attention-deficit/hyperactivity disorder is
related to glutamatergic dysfunction in the anterior cingulate
cortex. World J Biol Psychiatry. 19:538–546. 2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Lesch KP, Merker S, Reif A and Novak M:
Dances with black widow spiders: Dysregulation of glutamate
signalling enters centre stage in ADHD. Eur Neuropsychopharmacol.
23:479–491. 2013.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Cheng J, Liu A, Shi MY and Yan Z:
Disrupted glutamatergic transmission in prefrontal cortex
contributes to behavioral abnormality in an animal model of ADHD.
Neuropsychopharmacology. 42:2096–2104. 2017.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Srivastava AK, Khare P, Nagar HK,
Raghuwanshi N and Srivastava R: Hydroxyproline: A potential
biochemical marker and its role in the pathogenesis of different
diseases. Curr Protein Pept Sci. 17:596–602. 2016.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Baeza-Velasco C, Sinibaldi L and Castori
M: Attention-deficit/hyperactivity disorder, joint
hypermobility-related disorders and pain: Expanding body-mind
connections to the developmental age. Atten Defic Hyperact Disord.
10:163–175. 2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Doğan ŞK, Taner Y and Evcik D: Benign
joint hypermobility syndrome in patients with attention
deficit/hyperactivity disorders. Arch Rheumatol. 26:187–192.
2011.
|
|
26
|
Baeza-Velasco C, Grahame R and Bravo JF: A
connective tissue disorder may underlie ESSENCE problems in
childhood. Res Dev Disabil. 60:232–242. 2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Skalny AV, Skalny AA, Lobanova YN,
Korobeinikova TV, Ajsuvakova OP, Notova SV, Burtseva TI, Skalnaya
MG and Tinkov AA: Serum amino acid spectrum in children with autism
spectrum disorder (ASD). Res Autism Spectr Disord.
77(101605)2020.
|
|
28
|
Tinkov AA, Skalnaya MG and Skalny AV:
Serum trace element and amino acid profile in children with
cerebral palsy. J Trace Elem Med Biol. 64(126685)2021.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Oades RD, Dauvermann MR, Schimmelmann BG,
Schwarz MJ and Myint AM: Attention-deficit hyperactivity disorder
(ADHD) and glial integrity: S100B, cytokines and kynurenine
metabolism - effects of medication. Behav Brain Funct.
6(29)2010.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Holeček M: Histidine in health and
disease: Metabolism, physiological importance, and use as a
supplement. Nutrients. 12(848)2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Sasahara I, Fujimura N, Nozawa Y, Furuhata
Y and Sato H: The effect of histidine on mental fatigue and
cognitive performance in subjects with high fatigue and sleep
disruption scores. Physiol Behav. 147:238–244. 2015.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Yoshikawa T, Nakamura T, Shibakusa T,
Sugita M, Naganuma F, Iida T, Miura Y, Mohsen A, Harada R and Yanai
K: Insufficient intake of L-histidine reduces brain histamine and
causes anxiety-like behaviors in male mice. J Nutr. 144:1637–1641.
2014.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Holton KF, Johnstone JM, Brandley ET and
Nigg JT: Evaluation of dietary intake in children and college
students with and without attention-deficit/hyperactivity disorder.
Nutr Neurosci. 22:664–677. 2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Hallen A, Jamie JF and Cooper AJ: Lysine
metabolism in mammalian brain: An update on the importance of
recent discoveries. Amino Acids. 45:1249–1272. 2013.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Mikirova NA, Rogers AM, Taylor PR,
Hunninghake RE, Miranda-Massari JR and Gonzalez MJ: Metabolic
correction for attention deficit/hyperactivity disorder: A
biochemical-physiological therapeutic approach. Funct Food Health
Dis. 3:1–20. 2013.
|
|
36
|
Smriga M, Ando T, Akutsu M, Furukawa Y,
Miwa K and Morinaga Y: Oral treatment with L-lysine and L-arginine
reduces anxiety and basal cortisol levels in healthy humans. Biomed
Res. 28:85–90. 2007.PubMed/NCBI View Article : Google Scholar
|
